Baptista, R.P., Barata, D.M., Fonseca, L.P., Diogo, M.M., da Silva, C.L., Cabral, J.M.S. Production of recombinant Human Leukemia Inhibitory Factor (lif) in a Mammalian Cell Bioreactor: A first approach, in Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), (N. Jenkins, N. Barron & P.M. Alves, Eds.), 573-576 (2012).
Barbosa, H.S.C, Fernandes, T.G., Dias, T.P., Diogo, M.M., Cabral, J.M.S. New Insights into the Mechanisms of Embryonic Stem Cell Self-Renewal under Hypoxia: a Multifactorial Analysis Approach. PLoS One 7(6):e38963 (2012).
Coelho, M.B., Cabral, J.M.S., Karp, J.M. Intraoperative Stem Cell Therapy. Annu Rev Biomed Eng 14:325-349 (2012).
Diogo, M.M., da Silva C.L., Cabral J.M.S. Separation Technologies for Stem Cell Bioprocessing. Biotechnol Bioeng 109(11):2699-2709 (2012).
Madeira, A., da Silva, C.L., dos Santos, F., Camafeita, E., Cabral, J.M., Sá-Correia, I. Human Mesenchymal Stem Cell Expression Program upon Extended Ex-vivo Cultivation, as Revealed by 2-DE-Based Quantitative Proteomics. PLoS One 7(8):e43523 (2012).
Madeira, C., dos Santos F., Andrade, P.Z. Da Silva, C.L, Cabral, J.M.S. Mesenchymal stem cells for cellular therapies, in Stem cells and cancer stem cells, (M.A. Hayat Ed.), Springer Science Business Media, 3(3), 179-187 (2012).
Oliveira P.H., Boura J., Abecasis M.A., Gimble J.M., da Silva C.L. Cabral J.M.S. Impact of hypoxia and long-term cultivation on the genomic stability and mitochondrial performance of ex vivo expanded human stem/stromal cells. Stem Cell Res 9:225-236 (2012).
Ribeiro, S., Mairhofer, J., Madeira, C., Diogo, M., da Silva, C.L., Monteiro, G., Grabherr, R., Cabral, J.M. Plasmid DNA size does affect non-viral gene delivery efficiency in stem cells. Cell Reprogram 14(2):130-137 (2012).
Rodrigues, C.A.V., Fernandes, T.G, Diogo, M.M., Lobato da Silva, C., Cabral, J.M.S. Bioreactors for Stem Cell Expansion and Differentiation, in CRC Handbook of Biomedical Engineering, CRC Press.
Santhagunam, A., Madeira, C., Cabral J.M.S. Genetically engineered stem cell-based strategies for articular cartilage regeneration. Biotechnol Appl Biochem 59(2), 121-131 (2012).